• Arch Cardiovasc Dis · Nov 2014

    Multicenter Study Observational Study

    Melody ® transcatheter pulmonary valve implantation: results from a French registry.

    • Alain Fraisse, Philippe Aldebert, Sophie Malekzadeh-Milani, Jean-Benoit Thambo, Jean-François Piéchaud, Pascaline Aucoururier, Gilles Chatelier, Damien Bonnet, Laurence Iserin, Béatrice Bonello, Anass Assaidi, Issam Kammache, and Younes Boudjemline.
    • Cardiologie Pédiatrique, hôpital de la Timone-Enfants, 13385 Marseille, France.
    • Arch Cardiovasc Dis. 2014 Nov 1;107(11):607-14.

    BackgroundPercutaneous implantation of pulmonary valves has recently been introduced into clinical practice.AimTo analyse data of patients treated in France between April 2008 and December 2010.MethodsProspective, observational, multi-centric survey by means of a database registry of the Filiale de cardiologie pédiatrique et congénitale.ResultsSixty-four patients were included, with a median (range) age of 21.4 (10.5-77.3) years. The majority (60.9%) of the patients were New York Heart Association (NYHA) class II. The most common congenital heart disease was tetralogy of Fallot with or without pulmonary atresia (50%). Indication for valve implantation was stenosis in 21.9%, regurgitation in 10.9% and association of stenosis and regurgitation in 67.2%. Implantation was successful in all patients. Pre-stenting was performed in 96.9% of cases. Median (range) procedure time was 92.5 (25-250) minutes. No significant regurgitation was recorded after the procedure, and the trans-pulmonary gradient was significantly reduced. Early minor complications occurred in five cases (7.8%). Three patients died during a median follow-up of 4.6 (0.2-5.2) years, two from infectious endocarditis and one from end-stage cardiac failure. Surgical reintervention was required in three patients. Follow-up with magnetic resonance imaging demonstrated significant improvements in right ventricular volumes and pulmonary regurgitation in mixed and regurgitant lesions.ConclusionsTranscatheter pulmonary valve implantation is highly feasible and mid-term follow-up demonstrates sustained improvement of right ventricular function. Late endocarditis is of concern, therefore longer follow-up in more patients is urgently needed to better assess long-term outcome.Clinical Trial RegistrationNCT01250327.Copyright © 2014 Elsevier Masson SAS. All rights reserved.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…